- Research article
- Open Access
Purification, characterization and immunogenicity assessment of glutaminase free L-asparaginase from Streptomyces brollosae NEAE-115
BMC Pharmacology and Toxicology volume 19, Article number: 51 (2018)
L-asparaginase is a potential therapeutic enzyme widely used in the chemotherapy protocols of pediatric and adult patients with acute lymphoblastic leukemia. However, its use has been limited by a high rate of hypersensitivity in the long-term used. Hence, there is a continuing need to search for other L-asparaginase sources capable of producing an enzyme with less adverse effects.
Production of extracellular L-asparaginase by Streptomyces brollosae NEAE-115 was carried out using submerged fermentation. L-asparaginase was purified by ammonium sulphate precipitation and pure enzyme was reached using ion-exchange chromatography, followed by enzyme characterization. Anticancer activity towards Ehrlich Ascites Carcinoma (EAC) cells was investigated in female Swiss albino mice by determination of tumor size and the degree of tumor growth inhibition. The levels of anti-L-asparaginase IgG antibodies in mice sera were measured using ELISA method.
The purified L-asparaginase showed a total activity of 795.152 with specific activity of 76.671 U/mg protein and 7.835 − purification fold. The enzyme purity was confirmed by using SDS–PAGE separation which revealed only one distinctive band with a molecular weight of 67 KDa. The enzyme showed maximum activity at pH 8.5, optimum temperature of 37 °C, incubation time of 50 min and optimum substrate concentration of 7 mM. A Michaelis-Menten constant analysis showed a Km value of 2.139 × 10− 3 M with L-asparagine as substrate and Vmax of 152.6 UmL− 1 min− 1. The half-life time (T1/2) was 65.02 min at 50°С, while being 62.65 min at 60°С. Furthermore, mice treated with Streptomyces brollosae NEAE-115 L-asparaginase showed higher cytotoxic effect (79% tumor growth inhibition) when compared to commercial L-asparaginase group (67% tumor growth inhibition).
The study reveals the excellent property of this enzyme which makes it highly valuable for development of chemotherapeutic drug.
L-asparaginase (EC 22.214.171.124) is the enzyme that catalyzes the hydrolysis of L-asparagine to L-aspartic acid and ammonia. The leukemic cells cannot synthesize L-asparagine due the absence of L-asparagine synthetase . “These cells require huge amount of L-asparagine and rely on the exogenous sources for their proliferation and survival. Thus, intravenously injection of L-asparaginase in cancer patients destroys the exogenous L-asparagine and results in depletion of L-asparagine in the blood. L-asparagine starvation affecting selectively the tumor cells, since they are unable to complete protein synthesis ”. On the contrary, normal cells are protected from L-asparagine starvation due to their ability to synthesize this amino acid which is essential for both cell survival and protein synthesis . Hence, in combination therapy of children acute lymphoblastic leukemia (ALL), L-asparaginase is considered as the effective drug of choice [4, 5]. In addition, L-asparaginase is significantly used for the treatment of other malignant disorders including lymphosarcoma, acute lymphoblastic leukemia, chronic lymphocytic leukemia, acute myelomonocytic leukemia, acute myelocytic leukemia, Hodgkin disease, melanosarcoma and reticulosarcoma .
Currently, two formulations of L-asparaginases are effectively in clinical use for ALL treatments, one from Erwinia chrysanthemi and the other from E. coli. However, its therapeutic long-term use leads to unpleasant side effects as a result of exerting normal cells toxicity, patient’s hypersensitivity and the rapid clearance of the enzyme from the blood stream which limited its administration. Clinical uses indicate that the L-asparaginases toxicity is mainly resulted from enzyme glutaminase activity and bacterial endotoxins in enzyme preparations . Hepatotoxicity is the important adverse effect in the majority of patients , L-asparaginase causes a wide spectrum of side effects, such as skin rashes, fever, hepatic dysfunction, leucopoenia, pancreatitis, diabetes, neurological seizures and abnormal coagulation tests that may lead to intracranial thrombosis or haemorrhage . L-asparaginase purification consider as an essential step for its physical and biological characterization. Moreover, for effective therapeutic administration with less adverse effects, L-asparaginase preparation must be free of any contaminants and impurities which also required efficient purification step.
In an attempt to minimize the allergenic reactions caused by impurities, enormous numbers of research groups have achieved production and purification of L-asparaginase . Manivasagan et al.  reported that actinomycetes have been recognized to be a good source for L-asparaginase production, in particular Streptomyces species which are responsible for providing almost half of the useful drugs of bioactive secondary metabolites, especially antibiotics followed by enzymes and anti cancer agents. Several Streptomyces species have been explored for L-asparaginase production such as Streptomyces parvus NEAE-95 , Streptomyces olivaceus NEAE-119  and Streptomyces gulbargensis . The aim of the present work is the purification, characterization and immunogenicity assessment of an extracellular L-asparaginase produced under submerged fermentation from Streptomyces brollosae NEAE-115.
Microorganisms and cultural conditions
Soil samples collected from different areas in Egypt “Mansoura city, Damietta city, north western coast of Egypt from New Borg El-Arab to El Saloum, Janaklis (Beheira) and Brollos Lake” and three soil samples collected from Taif in Saudi Arabia were used for the isolation of actinomycetes, mainly Streptomyces spp. Streptomyces brollosae NEAE-115 was isolated from soil sample collected from Brollos Lake at the Mediterranean coast of Egypt. Streptomyces spp. had been isolated from the soil using standard dilution plate method on starch nitrate agar medium containing the following constituents (g/L): Starch, 20; CaCO3, 3; MgSO4.7H2O, 0.5; KNO3, 2; NaCl, 0.5; K2HPO4, 1; FeSO4.7H2O, 0.01; agar, 20. The incubation was carried at 30 °C for a period of 7 days. The obtained isolates of Streptomyces were purified and stored as spore suspensions in 20% (v/v) glycerol at − 20 °C for subsequent investigation.
Screening of L-asparaginase production by plate assay method
According to De Jong , an increase in the culture filtrates pH is accompanied by L-asparaginase production. All actinomycetes isolates were tested for their abilities to produce L-asparaginase using plates containing asparagine dextrose salts agar (ADS agar) medium . The constituents of the ADS agar medium were (%): L-asparagine 1.0; K2HPO4 0.1; MgSO4 0.05; dextrose 0.2; agar 1.5, pH was adjusted to 6.8–7. The medium was incorporated with pH indicator (phenol red, 0.009% w/v) prepared in ethanol according to the procedure of Gulati et al. . The actinomycetes isolates were inoculated on ADS agar plates and incubated at 30 °C for 7 days. The formation of a pink zone around the microbial colonies due to change of pH was considered as a positive result for L-asparaginase production . Two control plates were prepared one was uninoculated medium while the other was without dye. The more potent isolate exhibiting L-asparaginase activity was selected for further study.
Three disks (8 mm each) were taken from old stock culture grown on starch nitrate agar medium for 7 days and inoculated into 50 mL of asparagine dextrose salts broth containing (%): L-asparagine 1.0; K2HPO4 0.1; dextrose 0.2; MgSO4 0.05. The inoculated 250 mL Erlenmeyer flasks were grown at 30 °C and 150 rpm for 48 h and cultured medium was further used for subsequent experiments.
Production of L-asparaginase by submerged fermentation
The production of extracellular L-asparaginase from Streptomyces brollosae NEAE-115 was carried using the medium containing (g/L): Dextrose 2, starch 20, L-asparagine 10, KNO3 1, K2HPO4 1, MgSO4.7H2O 0.5, NaCl 0.1, pH 7. Fifty mL of the broth medium was dispensed in 250 mL Erlenmeyer conical flask. The inoculated flasks (with inoculum size of 4%, v/v) were incubated on a rotary shaker incubator at 150 rpm and 30 °C. After 7 days of incubation time, the broth was centrifuged with cooling centrifuge at 6000×g for 30 min at 4 °C and the clear supernatant served as crude enzyme.
Assay of L-asparaginase activity
Extracellular L-asparaginase activity was determined according to the method of Wriston and Yellin  using nesslerization to measure the amount of liberated ammonia. The reaction mixture containing 1.5 mL of 0.04 M L-asparagine prepared in 0.05 M Tris-HCl buffer, pH 8.6 and 0.5 mL of the enzyme to make up the total volume to 2 mL. The tubes were incubated at 37 °C for 30 min. The reaction was terminated by the addition of 0.5 mL of 1.5 M trichloroacetic acid (TCA). The blank was run by adding TCA followed by enzyme preparation. To remove the precipitated protein, the reaction contents were centrifuged at 10,000×g for 5 min and the filtrate was collected. For quantification of liberated ammonia, 0.5 mL filtrate was diluted to 7 mL with distilled water and 1 mL Nessler’s reagent was added to the resulting mixture. The color reaction was allowed to proceed for 20 min before measuring the absorbance at 480 nm using Optizen Pop –UV/Vis spectrophotometer. A coloration of yellow indicates the presence of ammonia. However, a brown precipitate is formed at higher concentrations. The amount of liberated ammonia by the test sample was calculated by comparing the absorbance with a standard curve prepared from solutions of ammonium chloride as the ammonia source. One unit (U) of L-asparaginase is the amount of enzyme which generates 1μmole of ammonia in 1 min at 37 °C and pH 8.6.
Assay of L-glutaminase
L-glutaminase activity was determined using L-glutamine as substrate according to Imada et al.  method and the released ammonia was measured by using Nesseler’s reagent.
Purification of L-asparaginase from Streptomyces brollosae NEAE-115
The crude enzyme extract used in L-asparaginase purification was obtained from production medium centrifuged at 6000×g for 30 min and the resulted supernatant was transferred into a conical flask placed in ice cold condition with stirring. Finely powdered ammonium sulfate was added until complete dissolving takes place to give 45% saturation with ammonium sulphate and kept overnight in the refrigerator at 4 °C. The precipitate was collected by centrifugation at 11000×g for 30 min, while the supernatant was brought to 55–85% saturation with ammonium sulphate. Then, the formed precipitates were separately collected by centrifugation and dissolved in 50 mM Tris-HCl buffer pH 8.4. The dialysis of the ammonium sulphate was carried out in a pre-treated dialysis tube. Precipitate formed during dialysis was removed by centrifugation and was discarded. For the present study dialysis tubing (SERVA pro, 44,144, diameter 21 mm × 5 m) was used. After dialysis, the samples were used for protein estimation by the method of Lowry et al.  and enzyme was assayed by the direct nesslerization method according to the method of Wriston and Yellin  and stored at − 20 °C for further purification. The concentrated enzyme solution was applied to the ion exchange column of DEAE-Sepharose CL-6B (2.7 × 20 cm) that was pre-equilibrated with 50 mM Tris-HCl buffer (pH 8.4). It was eluted with the same buffer containing increased concentration (0.1–0.5 M) of NaCl solution to elute the enzyme at a flow rate of 10 mL per 1 h. Fractions of 2 mL were collected, after fractions dialysis, the samples were subjected to protein estimation  and assay of L-asparginase activity . Fractions showing high L-asparaginase activity were collected for further use.
Physicochemical characterization of the purified enzyme
The optimum pH of the purified enzyme was studied over the pH range of 4.5 to 10.5 with L-asparagine as a substrate dissolved in different buffers of 0.05 M: citric acid- Na2HPO4 (pH 4.5–7.5), Tris-HCl (pH 8.5) and glycine-NaOH (pH 9.5–10.5). The influence of temperature on L-asparaginase activity was analysed by incubating the assay mixture over the temperature range of 25 to 60 °C in 0.05 M Tris-HCl buffer under assay conditions. The optimum substrate concentration for the enzyme activity was determined by incubating the purified enzyme in the presence of different substrate concentration (1–10 mM). To evaluate the incubation time effect on L-asparginase activity, the reaction mixture was incubated for different times (10, 20, 30, 40, 50, 60, 70 and 80 min). Along the characterization of the enzyme, activity was determined as reported earlier.
Determination of the kinetic parameters Km and Vmax
The kinetic parameters, Michaelis–Menten constant (Km) and maximal velocity (Vmax) of the purified L-asparaginase were determined with different concentrations of L-asparagine (1–10 mM) as substrate and the data were fitted to a one-phase exponential association nonlinear regression curve using GraphPad Prism 5 software (GraphPad Software Inc., San Diego, CA). The enzyme activity was determined by measuring the rate of hydrolysis of L-asparagine under standard assay conditions using the Michaelis–Menten equation:
Whereas: initial reaction velocity (V0), substrate concentration [S], the Michaelis-Menten constant (Km) and maximal velocity (Vmax).
Thermal stability of L-asparaginase
The stability of the L-asparaginase to temperature was determined by pre-incubating the reaction mixture (without its substrate) containing buffered enzyme for different time interval (0.0 to 90 min) with different temperatures (40, 50, 60, 70 and 80°С). After the end of the incubation periods, the enzyme was cooled and the residual activities were assayed.
Estimation of deactivation rate constant (kd) and half-life time (T1/2)
The heat inactivation half-life (T1/2) of the enzyme and thermal deactivation constant (kd) of the purified L-asparaginase produced by Streptomyces brollosae NEAE-115 were determined by using GraphPad Prism 5 software (GraphPad Software Inc., San Diego, CA). It was assumed that enzyme thermal deactivation is a reaction follows the first order kinetics (single step two-stage theory)  as follows:
Where, E is the active enzyme state and Ed is the deactivated state. The first order deactivation can be represented as follows:
Where, Kd is the deactivation rate constant, [E] is concentration of the active enzyme.
Eq. (3) integrated with the initial condition, gives:
This result is the exponential decay model. Therefore, by plotting log of (Ed/E) against time, the deactivation rate constant value (Kd) is obtained .
The half-life of the enzyme activity (T1/2) is the time it takes for the activity to reduce to a half of the initial activity value. The half-life time was determined by using the following equation:
Where: Kd is deactivation rate constant.
The deactivation rate constant (Kd) at each temperature was determined from Arrhenius equation as:
Plotting the log of Kd as a function of the inverse of the absolute temperature. The values of the deactivation energy (E) and k0 (frequency factor, min− 1) were obtained from the slope and intercept of the plot of ln (kd) versus (1/T); respectively. R is the universal gas constant and T is absolute temperature.
Effect of pH on L-asparaginase stability
To study the optimum pH for L-asparaginase stability, the enzyme in absence of its substrate was pre-incubated at room temperature for 0, 6, 12, 18, and 24 h in buffers of various pH values (pH 4.5–10.5). The residual activity was assayed under the standard assay conditions.
Effect of metal ions, inhibitors and surfactants on L-asparaginase activity
The effects of various metal ions, inhibitors and surfactants on L-asparaginase activity were determined by preincubating the enzyme with individual metal ions solutions prior to adding the substrate at a final concentration of 5 mM concentration and inhibitors and surfactants at 1 mM concentration for 30 min  at 4 °C. The residual activity of the enzyme was measured under the standard assay conditions. The relative activities were determined by considering 100% activity of the enzyme without the addition of metal ions or inhibitors or surfactants as control.
Molecular weight determination
The purity degree and the mass of the purified L-asparaginase enzyme was determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) according to the method of Laemmli  with a 10% separating acrylamide gel (pH 8.8) and a 5% stacking gel (pH 6.8) containing 0.1% SDS. Gels were stained with coomassie brilliant blue R-250 followed by distaining step with a mixture of methanol- acetic acid and water in the ratio of 4:1:5. Molecular weight of L-asparaginase was determined using standard molecular weight protein marker ranged from 9 to 178 kDa.
Female Swiss albino mice with body weight of 20–30 g were received from Urology and Nephrology Center of Mansoura University, Mansoura, Egypt, used to compare the cytotoxic effect of L-asparaginase purified from Streptomyces brollosae NEAE-115 and those commercially available L-asparaginase from E. coli (Sigma-Aldrich, Product Number: A3809; CAS Number: 9015–68-3). Animals were housed in a conditioned atmosphere at temperature of 24 ± 1 °C and 55 ± 5% relative humidity with regular 12 h light/12 h dark cycles and free access to standard laboratory food and water. All experiments have been conducted under the regulations and the ethical guidelines for laboratory animals approved by the Ethical Committee of Faculty of Pharmacy, Mansoura University, Egypt.
Transplantation of tumor
Ehrlich ascites carcinoma cells (EAC) were supplied by the Netherlands Cancer Institute. The cells were maintained in vivo in female Swiss albino mice by serial intraperitoneal transplantation  in the laboratory of Faculty of Pharmacy, Mansoura University, Egypt.
In vivo experiment and evaluation of antitumor activity
The 7–10 days old EAC cells were used along experiment. Ascites fluid from tumor-bearing mice was withdrawn using a needle aspiration under aseptic conditions from the peritoneal cavity, and subjected to three times washing with normal saline followed by centrifugation at 67×g. Tryphan blue exclusion test was used for tumor viability determination and haemocytometer was used for cells counting. To get ascitic fluid with a concentration of 5 × 105 viable EAC cells/0.1 mL of tumor cell suspension normal saline was used and was injected into the right thigh of the lower limb of mice to obtain ascitic tumor .
The largest tumor diameter and its perpendicular were measured by a digital caliper and used for tumor growth determination .
Whereas: largest tumor diameter (a) and its perpendicular (b).
When the primary tumor reached a size of 50–100 mm3, Swiss albino mice were divided into three groups of six each. Group (1) received normal saline (EAC-bearing control, 5 mL/kg). Group (2) received commercial L-asparaginase. Group (3) received L-asparaginase produced by Streptomyces brollosae NEAE-115. L-asparaginase treatments were given five days after the inoculation, two times a week for two weeks. After 24 h of the last dose and then 18 h of fasting, animals of each group were sacrificed by cervical dislocation to determine the antitumor activity of the tested L-asparaginase. Antitumor activity was calculated by the determination of ΔT (change of tumor size in the treatment group) and ΔC (change of tumor size in the control). The degree of tumor growth inhibition can be obtained from ΔT/ΔC X 100 .
Two groups each of 6 mice received intraperitoneal administration of either commercial L-asparaginase (250 U/kg) or Streptomyces brollosae NEAE-115 L-asparaginase (250 U/kg) twice a week for 4 weeks. Levels of specific antibodies (IgG immunoglobulin) against L-asparaginase or commercial product were measured in sera using ELISA method and microplate reader was used at absorbance of 450 nm. The direct enzyme-linked immunosorbent assay (ELISA) was carried out to evaluate the presence of asparaginase–specific IgG antibodies in serum samples by employing horseradish peroxidase–conjugated goat-anti mouse IgG (from Southern Biotech). All ELISA steps were conducted at room temperature, and 2.5% casein (w/v) was utilized as binding and blocking buffer. The assay steps and conditions were as follows: 2 h blocking of asparaginase-coated plates followed by extensive washing using PBS-Tween, incubated with diluted serum samples for 2 h, washed, incubated with detection antibody for 1 h, washed, developed with 3, 3′, 5, 5′-tetramethylbenzidine substrate for 30 min, and quenched with 9.8% (v/v) H2SO4 in water. IgG titers were calculated.
Production of the L-asparaginase by Streptomyces brollosae NEAE-115 was detected by plate assay. The enzyme production was indicated by color change in the medium from yellow to pink zone surrounding the colony. A broad diameter of the pink zone around the colony indicated that the organism was an efficient producer of L-asparaginase. During shake flasks production of L-asparaginase, the mycelial growth has been formed as large, spherical pellets which may lead to better yield of L-asparaginase than growth as free filaments. The glutaminase activity of L-asparaginase was investigated and the enzyme is free from glutaminase activity.
Purification of L-asparaginase from Streptomyces brollosae NEAE-115
Purification of L-asparaginase of Streptomyces brollosae NEAE-115 was carried out using crude culture filtrate having a total activity of 30538.87 U, protein content 3120.42 mg and specific activity of 9.786 U/mg protein. The dialysed ammonium sulphate concentrated enzyme had a specific activity of 69.004 U/mg protein with protein content of 158.86 mg and the enzyme recovery was 35.895% with purification fold of 7.051 (Table 1). The dialyzed enzyme obtained after ammonium sulphate precipitation was used to purify the enzyme with DEAE Sepharose CL-6B packed column which resulting 260 fractions with major L-asparaginase peak on the chromatogram (Fig. 1). The final purification step, DEAE Sepharose CL-6B column, showed a total enzyme activity of 795.152, protein content of 10.371 mg with enzyme specific activity of 76.671 U/mg of protein and the results of all purification steps applied to purify L-asparaginase produced by Streptomyces brollosae NEAE-115 are summarized in Table 1.
SDS-PAGE and molecular weight determination
The purity and molecular weight of the purified enzyme was determined by SDS-PAGE according to the method of Laemmli  with gel system contained a separating gel of 10% and a stacking gel 5%. After the electrophoresis, protein bands were visualized by staining with coomassie brilliant blue R-250. The resolved electrophoretic bands of the enzyme from different purification steps on the SDS-PAGE showed that the enzyme purity was successfully improved. SDS–PAGE separation of the enzyme preparation showed no detectable contamination and electrophoretic resolved only one distinctive band. By using different molecular markers with known molecular weight ranged from 9 to 178 kDa, the molecular mass of the purified L-asparaginase was estimated. The relative mobility (Rf) value was calculated for the distinctive single band. The calculated Rf value is compared with the different standard proteins of known molecular weight. Hence the molecular weight for individual band is determined with a molecular mass of 67 kDa (Fig. 2).
Physicochemical properties of the purified L-asparaginase
The purified L-asparginase of Streptomyces brollosae NEAE-115 was characterized for its activity at different pH levels, temperatures, substrate concentrations and incubation times.
Effect of pH on L-asparaginase activity
The pH of the reaction played a vital role in most of enzymatic processes. There are number of reports on the enzyme activity at near physiological range. Fig. 3 shows that the purified L-asparaginase was active over a broad pH range of 4.5 to 10.5 with an optimum of 48.462 U/mL at pH 8.5. At higher pH’s, the enzyme activity was decreased. The enzyme retains 71.595% activity even at pH 10.5 and 58.919% at pH 5.5.
Incubation time effect on enzyme activity
L-asparaginase activity of Streptomyces brollosae NEAE-115 (Fig. 4) was gradually increased with increasing incubation time up to 50 min (L-asparaginase activity of 71.327 U/mL). After which only a slight decrease in L-asparaginase activity was observed.
Temperature effect on L-asparaginase activity
Figure 5 shows that the purified L-asparaginase was active over a wide range of temperature range of 25 to 60 °C with an optimum L-asparaginase activity of 87.81 U/mL at 37 °C and lower L-asparaginase activity observed at higher temperatures.
Effect of substrate concentration on the activity of L-asparaginase
The results in Fig. 6 showed the effect of various substrate concentrations ranging from 1 to 10 mM on the activity of L-asparaginase and verified the optimum required substrate concentration that gives the maximum L-asparaginase activity. The obtained results illustrated a gradual enzyme activity increase with increasing of the substrate concentration up to 7 mM demonstrating the optimum substrate concentration for enzyme activity. However, higher substrate concentration (8 to 10 mM) resulted in decreasing of enzyme activity. Activation of asparagine hydrolysis was investigated in terms of change in values of kinetic constants (Km and Vmax). The Km and Vmax values were calculated through Michaelis-Menten plot by plotting the relation between different substrate concentrations [S] versus enzyme activity (V), using enzyme kinetic template of Graph-Pad Prism 4 software. Michaelis-Menten plot showed in Fig. 7 illustrated the Km and Vmax values for L-asparaginase enzyme. The plot gave Km value of 2.139 × 10− 3 M and Vmax of 152.6 UmL− 1 min− 1 for the hydrolysis of L-asparagine by L-asparaginase from Streptomyces brollosae NEAE-115 and Km value of 1.76 × 10− 4 M and Vmax of 121.7 UmL− 1 min− 1 for the hydrolysis of L-asparagine by commercially available L-asparaginase from E. coli (Sigma-Aldrich, Product Number: A3809; CAS Number: 9015–68-3).
The temperature impact on L-asparaginase stability was studied and the maximum L-asparaginase stability was recorded at 40 °C (Fig. 8) with retained enzyme activity of 97.44% from initial activity after incubation time of 20 min. However, enzyme exposure to higher temperature and longer incubation time of 50 °C and 80 °C for 90 min led to observed rapid decrease in L-asparaginase activity with residual activity of 31.84 and 7.69%; respectively.
On the other hand, to reveal heat inactivation half-life time (T1/2) of the enzyme at the used temperatures and heat deactivation constant (kd), the linear regression of the obtained results was performed using Graph-Pad Prism software by fitting the data points to first order equation according to Eqs. (4) and (5) and their values were listed in Table 2. The stability of L-asparaginase was expressed as a percentage of residual activity compared to the initial activity of the un-treated enzyme activity which considered as a control (100%). The enzyme half life time (T1/2) of L-asparaginase was found to be 65.02 min at 50°С and 62.65 min at 60°С. However, enzyme activity destruction was recorded at 80 °C with low half-life time (49.60 min).
The purified L-asparaginase was more stable in alkaline pH than the acidic one; it retains 92.81% activity at pH 8.5 even after incubation for 6 h and 61.64% activity after 24 h (Fig. 9). Moreover, the enzyme retains about 84.22% of its activity after 6 h at the pH 9.5. At pH 4.5 the enzyme retained 64.80% activity after 6 h and the residual activity was 20.47% after 24 h. Half life time values in hours (T1/2) based on pH studies of L-asparaginase produced by Streptomyces brollosae NEAE-115 are represented in Table 3. The enzyme half life time of L-asparaginase was found to be 33.135 h at pH 8.5 and 28.506 h at pH 9.5. However, enzyme activity destruction was recorded at pH 4.5 with low half-life time (15.888 h).
Effect of metal ions, inhibitors and surfactants on L-asparaginase activity
The effect of various metal ions, inhibitors and surfactants on the enzyme activity is represented in Fig. 10. The purified L-asparaginase from Streptomyces brollosae NEAE-115 was not significantly affected by the presence of metal ions (Na+, K+, Fe2+) and β-mercaptoethanol. It is evident from the Fig. 10 that the enzyme activity enhanced considerably in the presence of Mg2+ (111.81%) and was maximal in the presence of Mn2+, Co2+ and Tween 80 by 145.15, 143.04 and 121.52%; respectively (acted as activators for L-asparaginase activity). However, a slight decrease, around 14.8 and 16%, in L-asparaginase activity was observed in the presence of Zn2+ and Ca2+; respectively. Moreover, the presence of EDTA and urea acted as inhibitors of L-asparaginase activity reducing its activity by 37.55 and 57.8%; respectively. The presence of Ni2+, Hg2+, Ba2+ and Cu2+ acted as a potent inhibitor, reducing about 74.68, 59.5, 56.4 and 49.8%; respectively of the L-asparaginase activity. The presence of sodium azide also acted as an inhibitor, reducing about 45.15% of the L-asparaginase activity.
Antitumor activity of purified L-asparaginase and immunogenicity assessment
Treatment with commercial L-asparaginase significantly decreased the relative tumor size compared to the control group, showing 33% tumor growth (i.e. 67% tumor growth inhibition). While mice treated with Streptomyces brollosae NEAE-115 L-asparaginase showed 79% tumor growth inhibition showing a significantly higher cytotoxic effect when compared to commercial L-asparaginase group (Table 4). One of the most important limitation of L-asparaginase as anticancer drug is that the allergic reactions exhibited by immune system of the patients receiving the medication of L-asparaginase. Characterization of the immunogenicity profile of L-asparaginase in mice and the levels of specific antibodies (IgG immunoglobulin) against L-asparaginase was measured in sera using ELISA method. Therapeutic efficacy and evaluation of anti-L-asparaginase IgG antibody concentrations in mice receiving Streptomyces brollosae NEAE-115 L-asparaginase preparations was carried out simultaneously with the commercial L-asparaginase in order to evaluate the superiority of the new product. There was a gradual increase in L-asparaginase IgG titre in both commercial L-asparaginase or Streptomyces brollosae NEAE-115 L-asparaginase-inoculated mice (Fig. 11). However significant anti-asparaginase IgG titer was observed in commercial L-asparaginase group when compared to the other group of mice inoculated by Streptomyces brollosae NEAE-115 L-asparaginase due to the highly immunogenic nature of the commercial asparaginase. The results demonstrated that the immunogenicity of the Streptomyces brollosae NEAE-115 L-asparaginase was remarkably reduced.
In the current study, L-asparaginase produced by Streptomyces brollosae NEAE-115 was detected by forming pink zone surrounding the colony. The pink zone resulted from the breakdown of amide bond in asparagine in the growth medium by L-asparaginase to aspartate and ammonia that changed the color of phenol red to pink .
The produced enzyme was partially purified by ammonium sulphate precipitation and pure enzyme was reached using ion-exchange chromatography. Recently L-asparaginase enzyme from strains Streptomyces noursei  and Streptomyces gulbergenesis  with an overall purification of 98.23 and 82.12 fold in final purification were carried out successfully. Sahu et al.  extracted the L-asparaginase from the actinomycete strain LA-29 isolated from the gut contents of the fish and the enzyme was purified 18-fold and from which 1.9% of protein was recovered and showed the specific activity of about 13.57 IU/mg of protein. Narayana et al.  and El-Bessoumy et al.  reported 99.3 and 106 fold purification of L-asparaginase from Streptomyces albidoflavus and Pseudomonas aeroginosa 50,071; respectively, by CM Sephedex C-50 column chromatography.
SDS–PAGE separation revealed only one distinctive band of the enzyme preparation, no detectable contamination. L-asparaginase was therefore a homogenous protein. The molecular weight for the individual band is determined with a molecular mass of 67 kDa. The molecular weight of the L-asparaginase was found to be varied according to the source of enzyme. Purified L-asparaginase from Bacillus sp. , Streptomyces gulbargensis , Streptomyces albidoflavus , Streptomyces PDK2 , and Streptomyces noursei  exhibited a molecular weight of 45, 85, 112, 140 kDa and 102 kDa; respectively.
The amidases enzymes such as L-asparaginase are generally stable and active at neutral and alkaline pH, whereas, earlier reporters showed optimum amidase activity at pH ranging from 5.0 to 9.0 . The optimum pH 8.5 was also reported for L-asparaginase purified from Streptomyces sp. PDK7 . However, the optimal L-asparaginase activity from Streptomyces gulbargensis was reported at pH 9.0 . Narayana et al.  have reported the maximum L-asparaginase at pH 7.5 by Streptomyces albidoflavus. Khamna et al.  have also reported maximum L-asparaginase activity at pH 7.0 using Streptomyces sp.
The L-asparaginase activity of Streptomyces brollosae NEAE-115 was gradually increased with increasing incubation time up to 50 min. However, longer time of incubation with substrate resulted in reduction of L-asparaginase activity which may due to the product inhibition. The purified L-asparaginase from Streptomyces noursei showed maximum activity at 35 min of incubation time . In addition, L-asparaginase purified from Pseudomonas aeruginosa 50,071 reached its maximum activity at 30 min .
L-asparaginase was active over a wide range of temperature from 25 to 60 °C with an optimum L-asparaginase activity of 87.81 U/mL at pH 37 °C and lower L-asparaginase activities observed at higher temperatures. Similarly, Siddalingeshwara and Lingappa  recorded optimum temperature 37 °C for maximum enzyme activity from Aspergillus terreus KLS2. This property of enzyme makes it most suitable for complete elimination of asparagine from the body when tumor patient treated with L-asparaginase. Comparable results were reported for the maximum activity of purified L-asparaginase from Streptomyces gulbargensis at 40 °C .
Michaelis-Menten plot gave a Km value of 2.139 × 10− 3 M with L-asparagine as substrate and Vmax of 152.6 UmL− 1 min− 1 for the hydrolysis of L-asparagine by L-asparaginase from Streptomyces brollosae NEAE-115 and Km value of 1.76 × 10− 4 M and Vmax of 121.7 UmL− 1 min− 1 for the hydrolysis of L-asparagine by commercially available L-asparaginase from E. coli (Sigma-Aldrich, Product Number: A3809; CAS Number: 9015–68-3). Senthil Kumar and Selvam  have reported the apparent Km and Vmax of 5.98 × 10− 2 M and 3.547 IU/μg; respectively in Streptomyces radiopugnans MS. Table 5 summerize the biochemical properties of some microbial L-asparaginases [13, 21, 22, 29, 30, 36,37,38,39,40,41,42,43,44,45,46,47,48].
L-asparaginase of different microbial sources has different Km value which defined as the half maximal velocity of the enzymatic reaction as a function of substrate concentrations and stating the filling of half of the enzyme active sites in the tested sample in the steady state. Therefore, Km values illustrate the affinity of the enzyme for its substrate . In consequence, lower and higher Km values mean stronger binding ability and lower enzyme affinity to its substrate; respectively. However, the kinetic constants of the enzymes in terms of Km and Vmax can be affected by many factors, including, enzyme type, enzyme different forms (crude, modified or purified), enzyme source, used conditions (temperature, pH, etc.), substrate type and the used procedure of assay . The rate of an enzyme-catalyzed reaction increases with the increasing of the substrate concentration beyond a certain level called maximal velocity rate (Vmax); at Vmax increase in substrate concentration does not cause any increase in reaction rate as there is no more enzyme available for reacting with substrate. The maximal rate, Vmax, reveals the number of substrate molecules converted into product by the enzyme per unit of time when the catalytic sites on the enzyme are fully saturated with its substrate .
According to the data reported under this investigation, the maximum thermal stability behavior of L-asparaginase was at 40 °C. An earlier study demonstrated by Senthil Kumar and Selvam , the pre incubation at 40 °C for 60 min of the purified L-asparaginase from Streptomyces radiopugnans MS1 resulted in no significant loss of enzyme activity. Similar results were recorded with many other microorganisms such as Streptomyces noursei , Pseudomonas stutzeri MB 405  and E. carotovora . “Enzyme stability and thermal deactivation are considered the major constraints in rapid development of biotechnology process. In addition, it considered a very important tool used in enzyme selection for industrial uses”.
The purified L-asparaginase was more stable in alkaline pH and similar findings were reported for L-asparaginase extracted from Pseudomonas stutzeri MB–405 which is maximally stable at pH range from 7.5 to 9.5  .
Among the different metal ions tested Mn2+ enhanced the L-asparaginase activity by 18% as reported by earlier workers on Fusarium culmorum ASP-87 and Mucor hiemalis [22, 53]. Husain et al.  reported that the monovalent cations such as Na+ and K+ enhanced the activity of Enterobacter cloacae L-asparaginase. K+ acted also as enhancer on Pectobacterium carotovorum asparaginase . Radha et al.  reported that the activity of Vibrio cholerae L-asparaginase was enhanced in presence of Ca2+ to 130%. Also, Meghavarnam and Janakiraman  reported that the non ionic surfactant tween 80 was found to enhance the activity of the enzyme by 16%. Senthil Kumar and Selvam  reported that the EDTA acts as an inducer in Streptomyces radiopugnans MS1. EDTA as metal chelator agent had no effect on P. carotovorum asparaginase . However, L-asparaginase was completely inhibited by EDTA as reported by Borkotaky and Bezbaruah . Whereas, EDTA inhibited the activity of fungal L-asparaginase from Trichoderma viride by 88% . Also, the L-asparaginase activity of Fusarium Culmorum ASP-87 was inhibited by EDTA, SDS and Cu2+ . Husain et al.  reported that the divalent and trivalent cations, Ca2+, Mg2+, Zn2+, Mn2+, and Fe3+ inhibited the enzyme activity. Radha et al.  reported that the activity of Vibrio cholerae L-asparaginase was inhibited by divalent cations Ni2+, Mg2+, Fe2+, Mn2+, Zn2+ and the complete loss in the activity was perceived in the presence Cu2+. Whereas, Archana and Raja  reported that Cu2+ inhibited the activity of L-asparaginase produced by Aspergillus nidulans by 84%. Kumar et al.  reported that Hg2+ inhibited the L-asparaginase activity produced by Pectobacterium carotovorum by 80%. However, L-asparaginase was completely inhibited by Fe2+ and Ni2+  and Cu2+ and Zn2+ . While, Husain et al.  reported that the asparaginase activity did not detected when enzyme was incubated with metal ions viz. Cd2+, Ni2+ and Hg2+. Other metal ions like Ca2+ and Mg2+ did not have much effect on enzyme activity  and β-mercaptoethanol did not have any effect on fungal L-asparaginase activity from Trichoderma viride .
Mn2+, Co2+ and Mg2+ ions increase the enzyme activity suggests that these metals ions can serve as co-factors, which can help to activate the enzymatic reaction. Mg2+ was thought to be the activating metal; Mg2+ may activate the substrate, bound directly to the enzyme-substrate complex. Mg2+ locks the enzyme-substrate complex in place and then rapidly causes release of the reaction products . This corresponds to fast dissociation rates for the enzyme-product complex rendering more favorable substrate binding sites. Metal ions play a crucial role in maintaining the active configuration of the enzymes at elevated temperatures by protecting them against thermal denaturation . It was reported that the divalent cations Mn2+ and Mg2+ increased the thermal stability of Bacillus alkaline proteases . Whereas, the monovalent cations, Na+ were found to enhanced asparaginase activity, indicates that the enzyme might contain Na+ ions . Thakur et al.  found that Mn2+ enhanced L-asparaginase activity and concluded that L-asparaginase is in general a metal-activated enzyme. Tween 80 was found to enhance the activity of the enzyme by 21.52%. Surfactants appear to increase quick and direct contact of enzymes with substrate sites . McAllister et al.  reported that Tween 80 increased the stability and substrate binding capacity of enzymes under in vitro conditions.
One of the most important limitation of L-asparaginase as anticancer drug is that the allergic reactions exhibited by immune system of the patients receiving the medication of L-asparaginase. The patient immune system reacts in many different ways against the drug such as, the development of high titers of serum IgG antibodies which in the majority of cases interfere with the therapeutic effect of the enzyme . Drug’s immunogenicity is fundamental obstacle which limits the therapy with foreign proteins in humans. A real immunological tolerance that would require antigen specific T-cell mediated immunosuppression is difficult to achieve. One way to overcome this problem for a limited time is to switch to another preparation .
This study is clearly revealed that soils can be considered as a rich source of L-asparaginase producing actinomycetes. Streptomyces brollosae NEAE-115 isolated from Egypt soil has the ability to produce a significant amount of L-asparaginase. A pure and efficient enzyme activity of L-asparaginase could be obtained using only two purification steps. The excellent characteristics of this enzyme like high catalytic activity over a wide range of temperature and pH, high substrate specificity, maximum activity at body temperature and its considerable thermal and pH stabilities, makes it highly valuable to be exploited as a potent anticancer agent. Furthermore, mice treated with Streptomyces brollosae NEAE-115 L-asparaginase showed 79% tumor growth inhibition with higher cytotoxic effect when compared to commercial L-asparaginase group. The current investigation concluded the isolated Streptomyces brollosae NEAE-115 used in this study could be a valuable potential source for L-asparaginase.
Enzyme-linked immunosorbent assay
- Km :
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
- T1/2 :
- Vmax :
Savitri AN, Azmi W. Microbial L-asparaginase: A potent antitumour enzyme. Indian J Biotechnol. 2003;2:184–94.
Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical evaluation of L-aspaprginase in the treatment of leukemia. Crit Rev Oncol Hematol. 2007;61:208–21.
Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E. Comparison of Escherichia coli–asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's leukemia group phase 3 trial. Blood. 2002;99:2734–9.
Ambi Rani S, Sundaram L, Vasantha P.B. A study on in vitro antioxidant and anticancer activity of L-asparaginase. J Pharm Res. 2011;5:1463–66.
El-Naggar NE, El-Ewasy SM, El-Shweihy NM. Microbial L-asparaginase as a potential therapeutic agent for the treatment of acute lymphoblastic leukemia: the pros and cons. Int J Pharmacol. 2014;10:182–99.
Verma N, Kumar K, Kaur G, Anand S. E. coli K-12 asparaginase-based asparagine biosensor for leukemia. Artif Cells Blood Substit Immobil Biotechnol. 2007;35:449–56.
Kotzia GA, Labrou NE. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase. J Biotechnol. 2005;119:309–23.
Ohnuma T, Holland JF, Freeman A, Sinks LF. Biochemical and pharmacological studies with L-asparaginase in man. Cancer Res. 1970;30:2297–305.
El-Naggar NE, Diras SF, Soliman HM, El-Deeb NM, El-Ewasy SM. Purification, characterization, cytotoxicity and anticancer activities of L-asparaginase, anti-colon cancer protein, from the newly isolated alkaliphilic Streptomyces fradiae NEAE-82. Sci Rep. 2016;6:32926.
Manivasagan P, Venkatesan J, Sivakumar K, Kim SK. Marine actinobacterial metabolites: current status and future perspectives. Microbiol Res. 2013;168:311–32.
El-Naggar NE. Extracellular production of the oncolytic enzyme, L-asparaginase, by newly isolated Streptomyces sp. strain NEAE-95 as potential microbial cell factories: Optimization of culture conditions using response surface methodology. Curr Pharm Biotechnol. 2015;16:162–78.
El-Naggar NE, Moawad H, El-Shweihy NM, El-Ewasy SM. Optimization of culture conditions for production of the anti-leukemic glutaminase free L-asparaginase by newly isolated Streptomyces olivaceus NEAE-119 using response surface methodology. Biomed Res Int. 2015;627031. https://doi.org/10.1155/2015/627031.
Amena S, Vishalakshi N, Prabhakar M, Dayanand A, Lingappa K. Production, purification and characterization of L-asparaginase from Streptomyces gulbargensis. Brazil J Microbiol. 2010;41:173–8.
De Jong PJ. L-asparaginase production by Streptomyces griseus. Appl Microbial. 1972;23:1163–4.
Saxena RK, Sinha U. L-asparaginase and glutaminase activities in culture filtrates of Aspergillus nidulans. Curr Sci. 1981;50:218–9.
Gulati R, Saxena R, Gupta R. A rapid plate assay for screening L-asparaginase producing microorganisms. Lett Appl Microbiol. 1997;24:23–6.
Wriston J, Yellin T. L-asparaginase: a review. Adv Enzymol Relat Areas Mol Biol. 1973;39:185–248.
Imada A, Igarasi S, Nakahama K. Isona. M. Asparaginase and glutaminase activities of microorganisms. J Gen Microbiol. 1973;76:85–99.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.
Sadana A. Biocatalysis: fundamentals of enzyme Deactvation kinetics. Englewood Cliffs: Prentice-Hall, Inc.; 1995.
Radha R, Arumugam N, Gummadi SN. Glutaminase free L-asparaginase from Vibrio cholerae: heterologous expression, purification and biochemical characterization. Int J Biol Macromol. 2018;4(111):129–38.
Meghavarnam AK, Janakiraman S. Purification and characterization of therapeutic enzyme L-asparaginase from a tropical soil fungal isolate Fusarium culmorum ASP-87. MOJ Proteomics Bioinform. 2015;2(6):1–6.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5.
Gothoskar SV, Ranadive KJ. Anticancer screening of SAN-AB: an extract of marking nut, semecarpus anacardium. Indian J Exp Biol. 1971;9:372–5.
Raja Naresh RA, Ndupa N, Uma DP. Effect of macrophage activation on niosome encapsulated bleomycin in tumor-bearing mice. Ind J Pharamcol. 1996;28:175–80.
Schirner M, Hoffmann J, Menrad A, Schneider MR. Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res. 1998;4:1331–6.
Sahu MK, Poorani E, Sivakumar K, Thangaradjou T, Kannan L. Partial purification and anti-leukemic activity of L-asparaginase enzyme of the actinomycete strain LA-29 isolated from the estuarine fish. Mugil cephalus (Linn). J Environ Biol. 2007;28:645–50.
Dharmaraj S. Study of L-asparaginase production by Streptomyces noursei MTCC 10469, isolated from marine sponge Callyspongia diffusa. Iran J Biotechnol. 2011;9:102–8.
Narayana K, Kumar K, Vijayalakshmi M. L-asparaginase production by Streptomyces albidoflavus. Indian J Microbiol. 2008;48:331–6.
El-Bessoumy AA, Sarhan M, Mansour J. Production, isolation, and purification of L-asparaginase from Pseudomonas aeruginosa 50071 using solid-state fermentation. J Biochem Mol Biol. 2004;37:387–93.
Moorthy V, Ramalingam A, Sumantha A, Shankaranaya RT. Production, purification and characterisation of extracellular L-asparaginase from a soil isolate of Bacillus sp. Af J Microbiol Res. 2010;4:1862–7.
Dhevagi P, Poorani E. Isolation of L-asparaginase producing actinomycetes from marine sediments. Int J Curr Res Aca Rev. 2016;4:88–97.
Ohshima M, Yamamoto T, Soda K. Further characterization of glutaminase isozymes from Pseudomonas aeruginosa. Agri Biol Chem. 1976;40:2251–6.
Khamna S, Yokota A, Lumyong S. L-asparaginase production by actinomycetes isolated from some Thai medicinal plant rhizosphere soils. Int J Integ Biol. 2009;6:1–22.
Siddalingeshwara KG, Lingappa K. Production and characterization of L-asparaginase- a tumour inhibitor. Int J Pharm Tech Res. 2011;3:314–9.
Senthil Kumar M, Selvam K. Isolation and purification of high efficiency L-asparaginase by quantitative preparative continuous elution SDS PAGE electrophoresis. J Microbial Biochem Technol. 2011;3:073–83.
Husain I, Sharma A, Kumar S, Malik F. Purification and characterization of glutaminase free asparaginase from Enterobacter cloacae: In-Vitro evaluation of cytotoxic potential against human myeloid leukemia HL-60 cells. PLoS One. 2016;11(2):e0148877.
Manna S, Sinha A, Sadhukhan R, Chakrabarty S. Purification, characterization and antitumor activity of L-asparaginase isolated from Pseudomonas stutzeri MB-405. Curr Microbiol. 1995;30:291–8.
Nilolaev AI, Sokolov NN, Kozlov EA, Kutsman ME. Isolation and properties of a homogeneous L-asparaginase preparation from Pseudomonas fluorescens AG. Biokhimiia. 1975;40:984–9.
Gaffar SA, Shethna YI. Purification and some biological properties of asparaginase from Azotobacter vinelandii. Appl Environ Microbiol. 1977;33:508–14.
Cedar H, Schwartz JH. Localization of the two L-asparaginases in anaerobically grown Escherichia coli. J Biol Chem. 1967;242:3753–4.
Whelan BA, Wriston JC. Purification and properties of asparaginase from Escherichia coli B. Biochemist. 1969;8:2386–93.
Willis RC, Woolfolk CA. Asparagine utilization in Escherichia coli. J Bacteriol. 1974;118:231–41.
Tiwari N, Dua RD. Purification and preliminary characterization of L-asparaginase from Erwinia aroideae NRRL B-138. Indian J Biochem Biophys. 1996;33:371–6.
Mesas JM, Gil JA, Martín JF. Characterization and partial purification of L-asparaginase from Corynebacterium glutamicum. J Gen Microbiol. 1990;136:515–9.
Law AS, Wriston JC Jr. Purification and properties of Bacillus coagulans L-asparaginase. Arch Biochem Biophys. 1971;147:744–52.
Mahajan RV, Kumar V, Rajendran V, Saran S, Ghosh PC, Saxena RK. Purification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from Bacillus licheniformis: In vitro evaluation of anti-cancerous properties. PLoS One. 2014;9(6):e99037.
Dias FFG, Ruiz ALTG, Della Torre A, Sato HH. Purification, characterization and anti-proliferative activity of L-asparaginase from Aspergillus oryzae CCT 3940 with no glutaminase activity. Asian Pac J Trop Biomed. 2016;6:785–94.
Wulff G. Enzyme-like catalysis by molecularly imprinted polymers. Chem Reviews. 2002;102:1–28.
Copeland RA. Enzymes, A practical introduction to structure, mechanism and data analysis. 2nd ed. New York: Wiley−VCH; 2000.
Bisswanger H.. Enzyme kinetics. Principles and Methods. 2nd ed. Wiley−VCH Verlag GmbH & Co.: Weinheim;2008.
Maladkar NK, Singh VK, Naik SR. Fermentative production and isolation of L-asparaginase from Erwinia carotovora, EC-113. Hindustan Antibiot Bull. 1992;35:77–86.
Thakur M, Lincoln L, Niyonzima FN, Sunil S. Isolation, purification and characterization of fungal extracellular L-asapraginase from Mucor hiemalis. J Biocat Biotrans. 2013;2:1–9.
Kumar S, Venkata Dasu V, Pakshirajan K. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. Bioresour Technol. 2011;102(2):2077–82.
Borkotaky B, Bezbaruah R. Production and properties of asparaginase from a new Erwinia sp. Folia Microbiol. 2002;47:473–6.
Lincoln L, Francois N, Niyonzima Sunil SM. Purification and properties of a fungal L-asparaginase from Trichoderma viride pers: SF GREY. J Microbiol Biotechnol Food Sci. 2015;4(4):310–6.
Archana Rani J, Raja RP. Production, purification and characterization of L-asparaginase from Aspergillus nidulans by solid substrate fermentation. Eur J Biotechnol Bio. 2014;2(4):51–8.
Raha SK, Roy SK, Dey SK, Chakrabarty SL. Purification and properties of an L-asparaginase from Cylindrocarpon obtusisporum MB-10. J Biochem Int. 1990;21:987–1000.
Selvakumar N, Vanajakumar and Natarajan R. Partial purification, characterization and antitumor properties of L-asparaginase (antileukemic agent) from a marine Vibrio. Bioactive compounds from marine organisms, Indo-US symposium 1989, edited by Thompson MF, Sarojini R and Nagabhushanam R. 1991;289–300.
Knape MJ, Ahuja GL, Bertinetti D, Burghardt NCG, Zimmermann B, Taylor SS, Herberg FW. Divalent metal ions Mg2+ and Ca2+ have distinct effects on protein kinase a activity and regulation. ACS Chem Biol. 2015;10(10):2303–15.
Kumar CG, Takagi H. Microbial alkaline proteases: from a bioindustrial viewpoint. Biotechnol Adv. 1999;17:561–94.
Moradian F, Khajeh K, Naderi-Manesh H, Sadeghizadeh M. Isolation, purification and characterization of a surfactants, laundry detergents and organic solvents-resistant alkaline protease from Bacillus sp. HR-08. Appl Biochem Biotechnol. 2009;159:33–45.
Castanon M, Wilke CR. Effect of the surfactant tween 80 on enzymatic hydrolysis of newspaper. Biotechno Bioengi Techno. 1981;23:1365–72.
McAllister TA, Stanford K, Bae HD, Treacher R, Hristov AN, Baah J, Shelford JA, Cheng KJ. Effect of a surfactant and exogenous enzymes on digestibility of feed and on growth performance and carcass traits of lambs. Canadian J Anim Sci. 2000;80:35–44.
Usman A. Seeking efficacy in L-asparaginase to combat acute lymphoblastic leukemia (ALL): a review. Afr J Pharm Pharm. 2015;9:793–805.
Neeta Asthana S, Azmi W. Microbial L-asparginase: A potent antitumor enzyme. Indian J Biotechnol. 2003;2:184–94.
The authors gratefully acknowledge the Science and Technology Development Fund (STDF), Egypt, for their financial support of this paper which is a part of the Grant No. 4943.
The Science and Technology Development Fund (STDF), Egypt.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable requests.
Ethics approval and consent to participate
The in vivo experimental protocol in this study was approved by the Research Ethics Committee, Faculty of pharmacy, Mansoura University, Mansoura, Egypt. All the experiments were performed in accordance with the relevant guidelines and regulations.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
El-Naggar, N.EA., Deraz, S.F., El-Ewasy, S.M. et al. Purification, characterization and immunogenicity assessment of glutaminase free L-asparaginase from Streptomyces brollosae NEAE-115. BMC Pharmacol Toxicol 19, 51 (2018). https://doi.org/10.1186/s40360-018-0242-1
- Streptomyces brollosae NEAE-115
- DEAE Sepharose CL-6B
- Immunogenicity assessment